These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9875096)

  • 1. T wave alternans after sotalol: evidence for increased sensitivity to sotalol after conversion from atrial fibrillation to sinus rhythm.
    Tan HL; Wilde AA
    Heart; 1998 Sep; 80(3):303-6. PubMed ID: 9875096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine.
    Hohnloser SH; van de Loo A; Baedeker F
    J Am Coll Cardiol; 1995 Oct; 26(4):852-8. PubMed ID: 7560608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation; sotalol vs bisoprolol.
    Plewan A; Lehmann G; Ndrepepa G; Schreieck J; Alt EU; Schömig A; Schmitt C
    Eur Heart J; 2001 Aug; 22(16):1504-10. PubMed ID: 11482924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sotalol-induced torsade de pointes: management with magnesium infusion.
    Arstall MA; Hii JT; Lehman RG; Horowitz JD
    Postgrad Med J; 1992 Apr; 68(798):289-90. PubMed ID: 1409197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of amiodarone versus sotalol in treatment of atrial fibrillation: a random controlled clinical study].
    Niu F; Huang CX; Jiang H; Yang B; Guo WL; Chen YX; Jin CR; Liu ZM
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):121-3. PubMed ID: 16620720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sotalol--atrial fibrillation, reduced renal function and sudden death].
    Bathen J; Madsen S
    Tidsskr Nor Laegeforen; 1998 Oct; 118(26):4086-7. PubMed ID: 9844513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.
    Fitton A; Sorkin EM
    Drugs; 1993 Oct; 46(4):678-719. PubMed ID: 7506652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Torsade de pointes secondary to d,l-sotalol after catheter ablation of incessant atrioventricular reentrant tachycardia--evidence for a significant contribution of the "cardiac memory".
    Haverkamp W; Hördt M; Breithardt G; Borggrefe M
    Clin Cardiol; 1998 Jan; 21(1):55-8. PubMed ID: 9474467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case series of sotalol-induced torsade de pointes in patients with atrial fibrillation--a tale with a twist.
    Tan HH; Hsu LF; Kam RM; Chua T; Teo WS
    Ann Acad Med Singap; 2003 May; 32(3):403-7. PubMed ID: 12854385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation.
    Juul-Möller S; Edvardsson N; Rehnqvist-Ahlberg N
    Circulation; 1990 Dec; 82(6):1932-9. PubMed ID: 2242519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained torsade de pointes occurring early during oral sotalol therapy for atrial fibrillation recurrence prophylaxis in a patient without heart disease.
    D'Aloia A; Faggiano P; Brentana L; Boldini A; Pedrinazzi C; Procopio R; Dei Cas L
    Int J Cardiol; 2005 Dec; 105(3):337-9. PubMed ID: 15985302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic effects of oral sotalol during both sinus rhythm and atrial fibrillation.
    Alboni P; Razzolini R; Scarfò S; Paparella N; Fucà G; Pedini I; Chioin R
    J Am Coll Cardiol; 1993 Nov; 22(5):1373-7. PubMed ID: 8227794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrocardiographic markers of repolarization heterogeneity during dofetilide or sotalol initiation for paroxysmal atrial fibrillation.
    Sauer AJ; Kaplan R; Xue J; Dorsey P; Hayes M; Shah SJ; Passman R
    Am J Cardiol; 2014 Jun; 113(12):2030-5. PubMed ID: 24793679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open label, randomised, crossover study comparing sotalol and atenolol in the treatment of symptomatic paroxysmal atrial fibrillation.
    Steeds RP; Birchall AS; Smith M; Channer KS
    Heart; 1999 Aug; 82(2):170-5. PubMed ID: 10409530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of sotalol (Darob) therapy in supraventricular tachyarrhythmias.
    Toporan D; Protopopescu T; Ioan A; Paraschiv A
    Rom J Intern Med; 1998; 36(3-4):207-17. PubMed ID: 10822517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioversion with sotalol in selected patients with vagally and adrenergically mediated paroxysmal atrial fibrillation.
    Yeşil M; Bayata S; Postaci N; Yücel O; Aslan O
    Angiology; 1999 Sep; 50(9):729-33. PubMed ID: 10496499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sotalol associated polymorphic ventricular tachycardia and coronary spasm.
    Lowe MD; Stone DL; Grace AA
    Heart; 1998 May; 79(5):518-20. PubMed ID: 9659206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of sotalol in patients with refractory atrial fibrillation or flutter.
    Gallik DM; Kim SG; Ferrick KJ; Roth JA; Fisher JD
    Am Heart J; 1997 Aug; 134(2 Pt 1):155-60. PubMed ID: 9313591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation.
    Frick M; Darpö B; Ostergren J; Rosenqvist M
    Eur Heart J; 2000 Jul; 21(14):1177-85. PubMed ID: 10924301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamic, pharmacokinetic and antiarrhythmic properties of d-sotalol, the dextro-isomer of sotalol.
    Advani SV; Singh BN
    Drugs; 1995 May; 49(5):664-79. PubMed ID: 7601009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.